Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2018-10-19 2018-10-17
Drug Identification Number 02370069 02370069
Brand name BENLYSTA BENLYSTA
Common or Proper name belimumab lyophilized powder for intravenous infusion belimumab lyophilized powder for intravenous infusion
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients BELIMUMAB BELIMUMAB
Strength(s) 400MG 400MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1x20mL 1x20mL
ATC code L04AA L04AA
ATC description IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-10-12 2018-10-12
Estimated end date 2018-10-25 2018-10-25
Actual end date 2018-10-18
Shortage status Resolved Actual shortage
Company comments
Health Canada comments